Compound Detail
CHEMBL5864526
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
O=C(OCc1ccc(OC(F)(F)F)cc1F)N1CCC2(CC1)CN(C(=O)[C@@H]1CCc3[nH]nnc3C1)C2.O=C(OCc1ccc(OC(F)(F)F)cc1F)N1CCC2(CC1)CN(C(=O)[C@H]1CCc3[nH]nnc3C1)C2
Basic Information
| ChEMBL ID | CHEMBL5864526 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GEFAERQRUSVKMP-IKFJUQJOSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
1023.0
MW (Da)
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Ataxin-2 CHEMBL1795085 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Ataxin-2 | IC50 | = | 1.0 | nM | 9.0 | Enzyme Inhibition Assay: ATX inhibition was measured by a fluorescence quenching... | - |
Data from ChEMBL 36 via Core Engine